Robot surgeons take on brain bleeds in major new trial

NCT ID NCT07205263

Recruiting now Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This large trial is testing whether AI-guided robotic surgery can improve outcomes for people with a hemorrhagic stroke (bleeding in the brain). The study will compare this new, less invasive technique to standard surgery or medical management. Researchers hope the robotic approach will lead to better recovery and less disability for the 1,000 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted robotic-guided surgery
What this could lead to: If successful, this could provide a safer, more effective surgical option for people with hemorrhagic stroke, potentially reducing disability and improving survival.
What could go wrong: This is a large trial, but the technology is new and complex. The benefits over standard surgery are not yet proven, and there are always risks with any brain surgery, such as infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL GANGLIA HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal ganglia cerebrovascular disorder Basal Ganglia Hemorrhage brain stem infarction intracerebral hemorrhage Intracranial Hemorrhages

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BASAL GANGLIA HEMORRHAGE BRAINSTEM STROKE INTRACRANIAL HEMORRHAGE, SPONTANEOUS INTRAVENTRICULAR HEMORRHAGE

Contacts and locations

Locations

The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.